Relay Therapeutics (RLAY) Common Equity (2019 - 2026)
Relay Therapeutics' Common Equity came in at $890.01 million for Q2 2026, up 33.7% from $665.66 million a year earlier and up 38.6% from the prior quarter.
Relay Therapeutics (RLAY) Common Equity (2019 - 2026) Analysis & Trends
At the end of FY2025, Relay Therapeutics' Common Equity was $567.06 million, down 27.1% from FY2024.
- Common Equity carries a five-year compound annual growth rate of -5.8% (FY2020 to FY2025).
- Going back by year, Common Equity was $777.79 million in FY2024 (+3.4%), $752 million in FY2023 (-20.9%), $950.22 million in FY2022 (+5.8%) and $897.81 million in FY2021 (+17.6%).
- The Q2 2026 figure represents the highest quarterly Common Equity since Q4 2022.
- Year-over-year, Common Equity increased in three of the last eight quarters, with an average decline of 3.3%.
- The fastest year-over-year change in Common Equity over five years came in Q3 2022 (growth of 75.1%), and the weakest in Q3 2025 (a decline of 27.6%).
- Business Quant data shows RLAY's Common Equity at $642.18 million (Q1 2026), $567.06 million (Q4 2025) and $607.71 million (Q3 2025) in the three quarters before Q2 2026.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Common Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 84.97 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | -5.94 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 41.98 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 41.95 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 50.37 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 11.69 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 11.83 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 85.49 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 20.25 Bn |
| 10 | Relay Therapeutics | 3.87 Bn | 3.87 Bn | - | 890.01 Mn |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 890.01 Mn |
| Mar 31, 2026 | 642.18 Mn |
| Dec 31, 2025 | 567.06 Mn |
| Sep 30, 2025 | 607.71 Mn |
| Jun 30, 2025 | 665.66 Mn |
| Mar 31, 2025 | 721.08 Mn |
| Dec 31, 2024 | 777.79 Mn |
| Sep 30, 2024 | 838.86 Mn |
| Jun 30, 2024 | 681.74 Mn |
| Mar 31, 2024 | 745.76 Mn |
| Dec 31, 2023 | 752.00 Mn |
| Sep 30, 2023 | 778.37 Mn |
| Jun 30, 2023 | 810.12 Mn |
| Mar 31, 2023 | 883.41 Mn |
| Dec 31, 2022 | 950.22 Mn |
| Sep 30, 2022 | 999.77 Mn |
| Jun 30, 2022 | 779.64 Mn |
| Mar 31, 2022 | 841.97 Mn |
| Dec 31, 2021 | 897.81 Mn |
| Sep 30, 2021 | 571.09 Mn |
Relay Therapeutics Common Equity API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=common-equity&ticker=RLAY&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "common-equity", "ticker": "RLAY", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=common-equity&ticker=RLAY&period=max&api_key=YOUR_API_KEY");
const data = await res.json();